Æterna Zentaris Completes Management Team with the Appointment of Chief Medical Officer

21-Aug-2007

Æterna Zentaris Inc. announced the filling of a key position completing the management team with the appointment of Paul Blake, M.D., as Senior Vice President and Chief Medical Officer.

Prior to joining Æterna Zentaris, Dr. Blake was Chief Medical Officer of Avigenics, Inc. In 2005, he was Senior Vice President, Clinical Research and Regulatory Affairs at Cephalon, Inc. before being promoted to Executive Vice President, Worldwide Medical & Regulatory Operations. From 1992 to 1998, he held the position of Senior Vice President and Medical Director, Clinical Research and Development at SmithKline Beecham Pharmaceuticals (now GSK).

Dr. Blake earned a medical degree from the London University, Royal Free Hospital. He was elected Fellow of the American College of Clinical Pharmacology, Fellow of the Faculty of Pharmaceutical Medicine, Royal College of Physicians in the UK, and is a Fellow of the Royal College of Physicians in the UK.

Following Dr. Blake's appointment, the Company's Executive Management Team is comprised of the following members: Paul Blake, M.D. ( Senior Vice President and Chief Medical Officer), Jürgen Engel, Ph.D. (Executive Vice President and Chief Scientific Officer), Ellen McDonald, M.B.A. (Senior Vice President, Business Operations and Chief Business Officer), Mario Paradis, C.A. (Senior Vice President, Administrative and Legal Affairs, and Corporate Secretary), Nicholas J. Pelliccione, Ph.D. (Senior Vice President, Regulatory Affairs and Quality Assurance), and Dennis Turpin, C.A. (Senior Vice President and Chief Financial Officer).

https://www.bionity.com/en/news/67677/terna-zentaris-completes-management-team-with-the-appointment-of-chief-medical-officer.html